Transaction · 0001649245-26-000009

Febbo Phillip G.

Febbo Phillip G., CS, MO, reported an open-market or private sale at VERACYTE, INC. involving 2705.000000 shares for an estimated $118105.17. Reported holdings after the transaction were 133048.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCS, MO
VCYTVERACYTE, INC.
Filing timeSep 04
Trade dateSep 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$42.53
Pre-filing
1mo ago +8.5%1w ago +1.9%1d ago +5.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

VCYT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
VCYT since 2026-09-04Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001649245-26-000009
Common Stock
Transaction date
Sep 04, 2026
Filed Sep 04, 2026, 11:54 PM · 0d delay
Shares
2.70k sh
$4.36k per share
Estimated value
-$11.8M
Computed from shares × price
Holdings after
133k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Scientific & Med Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does…

  2. F2

    The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

  3. F3

    Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided…

  4. F4

    Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided…

Original filing · 0001649245-26-000009
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

VCYT